Predictive factors of PFS and OS after ASCT
. | Univariate analysis, P . | . | Multivariate analysis, P . | . | ||
---|---|---|---|---|---|---|
Variable . | PFS . | OS . | PFS . | OS . | ||
LDH | .312 | .795 | NA | NA | ||
Histologic BM infiltration | .079 | .457 | NA | NA | ||
Extranodal involvement | .936 | .914 | NA | NA | ||
Bulky disease | .049 | .006 | .021 | .060 | ||
Splenomegaly | .347 | .834 | NA | NA | ||
CR before ASCT | .006 | .060 | >.999 | NA | ||
CR after ASCT | .003 | .047 | .220 | .320 | ||
Rituximab exposure | .024 | .267 | .340 | NA | ||
Molecular response | <.001 | .002 | <.001 | .051 |
. | Univariate analysis, P . | . | Multivariate analysis, P . | . | ||
---|---|---|---|---|---|---|
Variable . | PFS . | OS . | PFS . | OS . | ||
LDH | .312 | .795 | NA | NA | ||
Histologic BM infiltration | .079 | .457 | NA | NA | ||
Extranodal involvement | .936 | .914 | NA | NA | ||
Bulky disease | .049 | .006 | .021 | .060 | ||
Splenomegaly | .347 | .834 | NA | NA | ||
CR before ASCT | .006 | .060 | >.999 | NA | ||
CR after ASCT | .003 | .047 | .220 | .320 | ||
Rituximab exposure | .024 | .267 | .340 | NA | ||
Molecular response | <.001 | .002 | <.001 | .051 |
NA indicates not applicable.